Nownews財經新聞: 福大轉型跨足洗腎醫材 預計明年Q1試產、Q4量產

Nownews財經新聞 www.nownews.com

Want new traffic sources? Download a copy of our complimentary eBook today, and read about sources that most marketers are not aware of. From our sponsors

福大轉型跨足洗腎醫材　預計明年Q1試產、Q4量產 Aug 21st 2013, 08:35 〔記者楊伶雯╱台北報導〕根據統計，台灣每100萬人有2400人洗腎，洗腎密度居全球第一，估計健保洗腎費用達300億元；大陸的洗腎人口也相當多，遠高出台灣百倍，估計每年全球洗腎醫療耗材上看800億元，看準洗腎耗材的市場大餅，福大（4402）轉型跨足洗腎醫材領域，研發生產中空纖維膜，總經理楊浩維指出，今年第4季將導入相關設備、預計2014年第1季試產，在取得美國及歐洲認證後，最快第4季量產。

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions